Wealthspire Advisors (New York)
CRMD icon

Wealthspire Advisors (New York)’s CorMedix CRMD Stock Holding History

Wealthspire Advisors (New York)’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,100
Closed -$24.4K – 1431
2025
Q3 		$24.4K Buy
+2,100
New +$25.4K ﹤0.01% 1574

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Oberweis Asset Management
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Wealthspire Advisors (New York)'s CRMD Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of CorMedix (CRMD) in Q4 2025, closing a stake of 2,100 shares — an estimated $24.4K sold.

Wealthspire Advisors (New York) first reported a position in CRMD in Q3 2025 and held it in 1 quarter. The position peaked at $24.4K in Q3 2025. 198 funds tracked by Wall St. Rank hold CRMD as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining CorMedix position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 2,100 CorMedix shares in Q4 2025, an estimated $24.4K.
  • Wealthspire Advisors (New York) first reported a position in CorMedix in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s CorMedix position peaked at $24.4K in Q3 2025.
  • 198 funds tracked by Wall St. Rank held CorMedix as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.